The p16 (CDKN2a/INK4a) Tumor-Suppressor Gene in Head and Neck Squamous Cell Carcinoma: A Promoter Methylation and Protein Expression Study in 100 Cases-Reference-Cited by-同舟云学术

The p16 (CDKN2a/INK4a) Tumor-Suppressor Gene in Head and Neck Squamous Cell Carcinoma: A Promoter Methylation and Protein Expression Study in 100 Cases

Published:2003-09 Issue:9 Volume:16 Page:944-950
ISSN:0893-3952
Container-title:Modern Pathology
language:
Short-container-title:Mod Pathol

Author:

Ai Lingbao,Stephenson Krystal K,Ling Wenhua,Zuo Chunlai,Mukunyadzi Perkins,Suen James Y,Hanna Ehab,Fan Chun-Yang

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Reference28 articles.

1. p16(MTS-1/CDKN2/INK4a) in Cancer Progression

2. The p16INK4a/CDKN2A tumor suppressor and its relatives

3. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing oral squamous cell carcinoma prediction: the prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins;Frontiers in Oncology;2023-12-22

2. Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models;Investigational New Drugs;2023-08-12

3. SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis;Cancer Letters;2023-07

4. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC;Frontiers in Genetics;2023-02-20

5. Experimental Model for Pancreatic Cancer and Its Therapeutic Implications in Clinical Research;Handbook of Animal Models and its Uses in Cancer Research;2023